180 related articles for article (PubMed ID: 9724101)
1. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.
Chandler LA; Sosnowski BA; McDonald JR; Price JE; Aukerman SL; Baird A; Pierce GF; Houston LL
Int J Cancer; 1998 Sep; 78(1):106-11. PubMed ID: 9724101
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
4. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.
Bachran C; Sutherland M; Heisler I; Hebestreit P; Melzig MF; Fuchs H
Exp Biol Med (Maywood); 2006 Apr; 231(4):412-20. PubMed ID: 16565437
[TBL] [Abstract][Full Text] [Related]
5. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
6. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
[TBL] [Abstract][Full Text] [Related]
7. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
[TBL] [Abstract][Full Text] [Related]
8. Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.
Berstad MB; Cheung LH; Berg K; Peng Q; Fremstedal AS; Patzke S; Rosenblum MG; Weyergang A
Oncogene; 2015 Oct; 34(44):5582-92. PubMed ID: 25684137
[TBL] [Abstract][Full Text] [Related]
9. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a saporin isoform with lower ribosome-inhibiting activity.
Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741
[TBL] [Abstract][Full Text] [Related]
11. HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells.
Ricci C; Polito L; Nanni P; Landuzzi L; Astolfi A; Nicoletti G; Rossi I; De Giovanni C; Bolognesi A; Lollini PL
J Immunother; 2002; 25(4):314-23. PubMed ID: 12142554
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.
Zhou X; Qiu J; Wang Z; Huang N; Li X; Li Q; Zhang Y; Zhao C; Luo C; Zhang N; Teng X; Chen Z; Liu X; Yu X; Wu W; Wei YQ; Li J
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1081-90. PubMed ID: 22392077
[TBL] [Abstract][Full Text] [Related]
14. A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins.
Heisler I; Keller J; Tauber R; Sutherland M; Fuchs H
Int J Cancer; 2003 Jan; 103(2):277-82. PubMed ID: 12455044
[TBL] [Abstract][Full Text] [Related]
15. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
16. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
[TBL] [Abstract][Full Text] [Related]
17. Pichia pastoris as a host for secretion of toxic saporin chimeras.
Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
[TBL] [Abstract][Full Text] [Related]
18. High-level expression and purification of heparin-binding epidermal growth factor (HB-EGF) with SUMO fusion.
Lu W; Cao P; Lei H; Zhang S
Mol Biotechnol; 2010 Mar; 44(3):198-203. PubMed ID: 19950003
[TBL] [Abstract][Full Text] [Related]
19. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
20. Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.
Armant DR; Kilburn BA; Petkova A; Edwin SS; Duniec-Dmuchowski ZM; Edwards HJ; Romero R; Leach RE
Development; 2006 Feb; 133(4):751-9. PubMed ID: 16407398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]